Paul Roepman MSc, PhD

Paul Roepman received his Ph.D. in the field of cancer genomics at the University Medical Center Utrecht in 2006 and continued his work on cancer gene (expression) profiling at Agendia (Amsterdam/Irvine CA). From 2014 to 2016, he got educated as a Clinical Molecular Biologist in Pathology (KMBP) at the St. Antonius Hospital (Utrecht) and the Radboudumc (Nijmegen). Paul moved to Hartwig Medical Foundation in 2017 to further improve the quality and utility of whole-genome sequencing (WGS) and to make this test ready for diagnostic use. In 2021, he also joined the team of molecular biologists at the Netherlands Cancer Institute to use WGS (and other technologies) in routine practice.